399.07MMarket Cap5.17P/E (TTM)
0.000High0.000Low0Volume0.000Open2.980Pre Close0.00Turnover0.00%Turnover Ratio5.17P/E (Static)133.91MShares3.32052wk High0.55P/B106.19MFloat Cap2.21052wk Low--Dividend TTM35.63MShs Float14.802Historical High--Div YieldTTM0.00%Amplitude1.832Historical Low--Avg Price1Lot Size
Global Cord Blood Stock Forum
$Snow Lake Resources(LITM.US)$ $Spero Therapeutics(SPRO.US)$ $McDonald's(MCD.US)$ $Johnson & Johnson(JNJ.US)$ $HHG Capital Corp(HHGC.US)$ $MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETN(NRGD.US)$ $Domino's Pizza(DPZ.US)$ $Global Cord Blood(CO.US)$ $Equity Residential(EQR.US)$
• $Revlon(REV.US)$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $United States Steel(X.US)$ +6.4% (issues upside EPS guidance),
• $Ellington Financial(EFC.US)$ +5% (reports book value per share)
• $Aurora Mobile(JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $Citi Trends(CTRN.US)$ +4.4% (names new CFO)
• $Roku Inc(ROKU.US)$ +4.2% (ROKU an...
• $Veru Inc(VERU.US)$ +25.8% (announces that in a Pre-EUA meeting held May 10 2022 FDA has agreed that the efficacy and safety data from the completed Phase 3 clinical study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome are sufficient to support the submission of a request for Emergency Use Authorization)
• $Desktop Metal(DM.US)$ +15.8% (prices offering of $100 mln of 6.0% convertible se...
• $SailPoint Technologies(SAIL.US)$ +30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash)
• $Veru Inc(VERU.US)$ +28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy)
• $Affimed NV(AFMD.US)$ +12.9% (Presents Upda...
Earnings result will be on 1st March. Hope it will drive up the price to above 6 dollars or more. With advance technology in China, stem cells and cord blood should be lucrative business but not sure what went wrong in not driv...
No comment yet